List of Iluvien drug patents
Iluvien is owned by Alimera Sciences Inc.
Iluvien contains Fluocinolone Acetonide.
Iluvien has a total of 1 drug patent out of which 0 drug patents have expired.
Iluvien was authorised for market use on 26 September, 2014.
Iluvien is available in implant;intravitreal dosage forms.
The generics of Iluvien are possible to be released after 12 August, 2027.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8871241 | ALIMERA SCIENCES INC | Injectable sustained release delivery devices |
Aug, 2027
(4 years from now) | |
Drugs and Companies using FLUOCINOLONE ACETONIDE ingredient
Market Authorisation Date: 26 September, 2014
Treatment: NA
Dosage: IMPLANT;INTRAVITREAL
ILUVIEN family patents
49
United States
13
Japan
12
China
12
European Union
11
Australia
9
Canada
9
Taiwan
7
Denmark
7
Spain
7
Slovenia
7
Argentina
6
Korea, Republic of
6
Austria
6
Mexico
5
New Zealand
5
Germany
5
Brazil
4
Cyprus
4
Portugal
3
Poland
2
Israel
2
Hong Kong
2
South Africa
1
EA
1
India
1
Malaysia
1
Norway
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic